H.R. 6897 · 118th Congress
Synthetic Biology and Active Pharmaceutical Ingredients Act
- Stage
- In committee
- Sponsor
- Elissa Slotkin
- Introduced
- 2023-12-22
- Latest action
- 2023-12-22 · Introduced in House
Summary
Synthetic Biology and Active Pharmaceutical Ingredients Act
This bill requires the Department of Defense (DOD) to establish a pilot program to support domestic manufacturing of critical pharmaceutical ingredients and their components through certain novel technology.
Specifically, DOD must establish a three-year program that uses technology involving synthetic biology to support domestic manufacturing of pharmaceutical ingredients and related incorporated materials that (1) are not available in a sufficient quantity or quality domestically, and (2) are strategically important to the United States.